Live Breaking News & Updates on Immuneering Company Profile
Stay updated with breaking news from Immuneering company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immuneering Co. (NASDAQ:IMRX) Given Consensus Recommendation of "Moderate Buy" by Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Immuneering Co. (NASDAQ:IMRX – Get Free Report) Director Peter Feinberg acquired 25,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $2.55 per share, for a total transaction of $63,750.00. Following the completion of the acquisition, the director now directly owns 111,766 shares […] ....
Immuneering Co. (NASDAQ:IMRX – Get Free Report) insider Harold Eugene Brakewood bought 3,900 shares of the stock in a transaction that occurred on Friday, March 22nd. The stock was bought at an average cost of $2.57 per share, for a total transaction of $10,023.00. Following the completion of the purchase, the insider now directly owns […] ....
Oppenheimer Reaffirms Outperform Rating for Immuneering (NASDAQ:IMRX) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Tucker Asset Management LLC bought a new stake in Immuneering Co. (NASDAQ:IMRX – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,036 shares of the company’s stock, valued at approximately $112,000. A number of other institutional investors also […] ....